Blog
OPAL Fuels (OPAL) Q2 Revenue Rises 13%
OPAL Fuels (NASDAQ:OPAL), a vertically integrated producer and distributor of renewable natural gas (RNG) and alternative fuels, reported its earnings for the second quarter of fiscal 2025 on August
Peakstone (PKST) Q2 AFFO Jumps 1,120%
Peakstone Realty Trust (NYSE:PKST), a real estate investment trust specializing in industrial and office properties, reported its second-quarter 2025 results on August 7, 2025. The headline news
Tectonic (TECX) Q2 R&D Soars 142%
Tectonic Therapeutic (NASDAQ:TECX), a biotechnology company advancing a new generation of biologic medicines for hard-to-treat diseases, reported its second quarter 2025 results on August 7, 2025
Guild (GHLD) Q2 EPS Jumps 57%
Guild (NYSE:GHLD), a nationwide mortgage lender focused on retail purchase originations and servicing, reported its second quarter 2025 results on August 7, 2025. The company announced non-GAAP
Crinetics (CRNX) Q2 Revenue Jumps 150%
Crinetics Pharmaceuticals (NASDAQ:CRNX), a biotechnology company focused on developing oral therapies for rare endocrine diseases, reported its latest quarterly results on August 7, 2025, for the
Brt Apartments (BRT) Q2 Revenue Up 1.4%
Brt Apartments (NYSE:BRT), an owner and operator of multi-family rental properties in high-growth U.S. regions, released its financial results on August 7, 2025. The company outperformed analyst
Main Street (MAIN) Q2 Revenue Up 9%
Main Street Capital (NYSE:MAIN), a business development company specializing in providing custom capital solutions to lower middle market businesses, reported Q2 FY2025 earnings on August 7, 2025
MicroVision (MVIS) Q2 Revenue Drops 92%
MicroVision (NASDAQ:MVIS), a company specializing in lidar (light detection and ranging) sensor hardware and integrated perception software for automotive, industrial, and defense markets, reported
89bio (ETNB) Q2 R&D Jumps 131%
89bio (NASDAQ:ETNB), a clinical-stage biotech focused on metabolic and liver diseases, released its second quarter 2025 results on August 7, 2025. The company posted GAAP earnings per share of
Clipper Realty (CLPR) Q2 NOI Hits Record
Clipper Realty (NYSE:CLPR), an owner and operator of multifamily and commercial properties focused in Manhattan and Brooklyn, shared its second quarter 2025 earnings results on August 7, 2025. The
RLJ Lodging (RLJ) Q2 FFO Beats by 77%
RLJ Lodging Trust (NYSE:RLJ), an urban-centric real estate investment trust (REIT) focused on premium-branded hotels, released its second quarter 2025 earnings on August 7, 2025. The company
Avita Medical (RCEL) Q2 Sales Up 21%
Avita Medical (NASDAQ:RCEL), a regenerative medicine innovator focused on wound care solutions, reported earnings for Q2 2025 on August 7, 2025. The main news was that commercial revenue rose to
Treace Medical (TMCI) Q2 Revenue Up 7%
Treace Medical Concepts (NASDAQ:TMCI), a medical device company focused on innovative solutions for surgical bunion correction and other foot deformities, reported its latest earnings results on
Arcosa (ACA) Q2 EPS Jumps 40%
Arcosa (NYSE:ACA), a diversified infrastructure products provider focused on construction materials, engineered structures, and transportation products, released its second-quarter 2025 results on
Victory Capital (VCTR) Q2 Revenue Up 60%
Victory Capital (NASDAQ:VCTR), a diversified global asset manager, released its earnings on August 7, 2025. The company posted standout financial results thanks to its acquisition of Amundi US
Elicio (ELTX) Q2 Loss Beats Estimates
Elicio Therapeutics (NASDAQ:ELTX), a biotechnology company focused on immunotherapies for cancer, reported its second quarter results on August 7, 2025, for the period ending June 30. The company
Willdan (WLDN) Q2 EPS Surges 173%
Willdan Group (NASDAQ:WLDN), an energy services and engineering firm focusing on modernizing power grids and improving energy efficiency, posted much higher-than-expected results for its second
Ultralife (ULBI) Q2 Revenue Rises 13%
Ultralife (NASDAQ:ULBI), a specialty battery and communications systems manufacturer, reported its second quarter 2025 earnings on August 7, 2025, covering the period ended June 30. The report
TaskUs (TASK) Q2 Revenue Jumps 24%
TaskUs (NASDAQ:TASK), a digital outsourcing provider focused on AI-powered customer support and content moderation, reported its fiscal second quarter 2025 earnings on August 7, 2025. The company
PACB Sales Up 11%
Pacific Biosciences (NASDAQ:PACB), a life sciences company specializing in DNA sequencing technology, published its latest earnings results for the fiscal second quarter ended June 30, 2025, on
Coherus (CHRS) Q2 Revenue Jumps 10%
Coherus Oncology (NASDAQ:CHRS), a biotechnology company focused on developing and commercializing innovative immuno-oncology therapies, reported earnings for Q2 2025 on August 7, 2025. The results
Karman (KRMN) Q2 Revenue Jumps 35%
Karman (NYSE:KRMN), a fast-growing engineering and manufacturing company specializing in mission-critical space and defense systems, reported results for the quarter ended June 30, 2025, on August
Concentra (CON) Q2 Revenue Jumps 15%
Concentra Group Parent (NYSE:CON), the United States' largest operator of occupational health centers, released its Q2 2025 earnings on August 7, 2025. The most notable news was that revenue (GAAP)
QuinStreet (QNST) Q4 Revenue Jumps 32%
QuinStreet (NASDAQ:QNST), a digital performance marketing company specializing in proprietary technologies and data-driven marketing for insurance and home services clients, released its Q4 and
Sweetgreen (SG) Q2 Sales Drop 7.6%
Sweetgreen, a fast-casual restaurant chain known for plant-forward salads and bowls, reported its financial results on August 7, 2025. The release revealed GAAP revenue of $185.6 million, missing


